ICAM1 and lymphoma: Our previous studies showed that in addition to its effects in PEL lines, Pom could also increase expression of B7-2 and ICAM-1 in EBV-infected lymphoma cell lines and lead to increased T-cell activation and NK cell recognition of these lines19.